2Quenel N, Mcquay HG, Fung GL, et al. The prognositic value of c - erbB - 2 in primary breast carcinomas [ J ]. Breast Cancer Res Treat, 1995,35 (3) :283 i- 291. 被引量：1
6Wu Y, Karas M, Duponl J, et al. Multiple signaling pathways are involved in the regulation of IGF - 1 receptor inhibition of PTEN - enhanced apoptosis [ J ]. Growth Horm IGF Res, 2004, 14(1) :52 -58. 被引量：1
7Yu Q, Geng Y,Sicinski P. Specific protection against breast cancers by cyclin D1 ablation [ J ]. Nature, 2001, 411 (6841) :1017 - 1021. 被引量：1
8Struewing JP, Abeliovich D, Peretz T,et al. The carrier fre- quency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals [ J ]. Nature Genet, 1995, 11 (10) : 198 - 200. 被引量：1
10Lemoine NR,Staddon S,Pickson C,et al.Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer[J].Oncogene,1990,5(2):237. 被引量：1
